George A. Kegler

Chief Financial Officer, Keenova Therapeutics plc.

Companies

Enveric Biosciences, Inc.Board member Jan 8, 2021 to now¹
Keenova Therapeutics plcChief financial officer Dec 14, 2018 to Jan 11, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Enveric Biosciences, Inc. ENVB26,418 shares³$37.0K at $1.40Jun 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 1, 2026Granted 18,518 shares of Enveric Biosciences, Inc.³
Dec 23, 2025Granted 7,633 shares of Enveric Biosciences, Inc.⁴
Oct 9, 2024Granted 47,733 shares of Enveric Biosciences, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREnveric Biosciences, Inc., Board member
2
SEC EDGARKeenova Therapeutics plc, Chief financial officer
3
SEC EDGAREnveric Biosciences, Inc. shares after the filing of Jun 1, 2026
4
SEC EDGARForm 4 filed Dec 30, 2025
5
SEC EDGARForm 4 filed Oct 11, 2024